Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MAXCYTE, INC. | President and CEO, Director | Common Stock | 100K | $490K | $4.90 | Jun 10, 2024 | Direct |
MAXCYTE, INC. | President and CEO, Director | Employee Stock Option (right to buy) | 400K | Jan 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MXCT | MAXCYTE, INC. | Jun 7, 2024 | 2 | $489K | 4 | Jun 10, 2024 | President and CEO, Director |
MXCT | MAXCYTE, INC. | Jan 3, 2024 | 1 | $0 | 4 | Jan 4, 2024 | President and CEO, Director |
MXCT | MAXCYTE, INC. | Mar 20, 2023 | 1 | $0 | 4 | Mar 21, 2023 | EVP and General Counsel |
MXCT | MAXCYTE, INC. | Mar 25, 2022 | 1 | $0 | 4 | Mar 29, 2022 | EVP and General Counsel |
MXCT | MAXCYTE, INC. | Nov 12, 2021 | 11 | -$738K | 4 | Nov 16, 2021 | EVP and General Counsel |
MXCT | MAXCYTE, INC. | Aug 9, 2021 | 1 | $0 | 4 | Aug 11, 2021 | EVP and General Counsel |
MXCT | MAXCYTE, INC. | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | EVP and General Counsel |